Therapeutic Asset Ratings
223 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Atezolizumab
Endometrial Clear Cell Adenocarcinoma
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Atezolizumab
Endometrial Mixed Adenocarcinoma
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Atezolizumab
Endometrial Endometrioid Adenocarcinoma
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Atezolizumab
Endometrial Serous Adenocarcinoma
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Atlcar.Cd30.Ccr4 Cells
Primary Cutaneous Anaplastic Large Cell Lymphoma
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Atlcar.Cd30.Ccr4 Cells
Primary Cutaneous Lymphoma
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Atlcar.Cd30.Ccr4 Cells
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma And Classical Hodgkin Lymphoma
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Atlcar.Cd30.Ccr4 Cells
Immune System Disorder
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Atlcar.Cd30.Ccr4 Cells
Immunoproliferative Disorder
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Atlcar.Cd30.Ccr4 Cells
Lymphatic System Disorder
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Atlcar.Cd30.Ccr4 Cells
Lymphomatoid Papulosis
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Atlcar.Cd30.Ccr4 Cells
Lymphoproliferative Syndrome
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Bendamustine
Primary Cutaneous Anaplastic Large Cell Lymphoma
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Bendamustine
Primary Cutaneous Lymphoma
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Bendamustine
Immune System Disorder
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Bendamustine
Immunoproliferative Disorder
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Bendamustine
Lymphomatoid Papulosis
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Bendamustine
Lymphoproliferative Syndrome
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
car138 t cells
Immune System Disorder
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Car.K.28
MALT Lymphoma
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Car.K.28
Nodal Marginal Zone B-Cell Lymphoma
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Chimeric Antigen Receptor Modified T Cells Infusion
Cutaneous Anaplastic Large Cell Lymphoma
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Chimeric Antigen Receptor Modified T Cells Infusion
Cutaneous Lymphoma
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Chimeric Antigen Receptor Modified T Cells Infusion
Gray Zone Lymphoma
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Chimeric Antigen Receptor Modified T Cells Infusion
Lymphomatoid Papulosis
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Showing 126 to 150 of 223 assets
Previous
Page 6 of 9
Next
